PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 52 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,023,235 | -6.2% | 331,100 | +36.7% | 0.00% | – |
| Q2 2023 | $1,090,323 | +31.1% | 242,294 | +66.1% | 0.00% | – |
| Q1 2023 | $831,652 | +95163.7% | 145,904 | +0.8% | 0.00% | – |
| Q4 2022 | $873 | -99.9% | 144,677 | -5.5% | 0.00% | – |
| Q3 2022 | $1,011,000 | +42.8% | 153,091 | +12.9% | 0.00% | – |
| Q2 2022 | $708,000 | -50.6% | 135,641 | -34.7% | 0.00% | – |
| Q1 2022 | $1,432,000 | -45.9% | 207,576 | -2.4% | 0.00% | – |
| Q4 2021 | $2,647,000 | -66.0% | 212,636 | -14.7% | 0.00% | -100.0% |
| Q3 2021 | $7,786,000 | +21.8% | 249,172 | +11.6% | 0.00% | 0.0% |
| Q2 2021 | $6,391,000 | -25.9% | 223,252 | +12.1% | 0.00% | 0.0% |
| Q1 2021 | $8,630,000 | -37.1% | 199,191 | +3.9% | 0.00% | -50.0% |
| Q4 2020 | $13,710,000 | – | 191,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |